Gilead (GILD) insider Daniel O'Day disclosed multiple sales totaling 40,000 shares

Rhea-AI Filing Summary

Form 144 filing for Gilead Sciences (GILD) reports proposed and recent insider sales of common stock by Daniel O'Day. The filing shows an intended sale of 10,000 shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $1,136,300 and an approximate sale date of 08/28/2025. The shares were originally acquired as restricted stock on 03/01/2022. The filer also reported three recent sales by the same person: 10,000 shares on 07/28/2025 for $1,139,369, 10,000 shares on 06/30/2025 for $1,104,483, and 10,000 shares on 05/30/2025 for $1,104,192. The filing lists 1,240,806,916 shares outstanding.

Positive

• Timely disclosure of multiple insider sales and a planned sale, fulfilling Rule 144 notification requirements
• Use of an established broker (Morgan Stanley Smith Barney LLC) for the planned transaction

Negative

• Insider selling of 40,000 shares in recent months may attract investor attention despite being small relative to outstanding shares

Insights

Securities Analyst

TL;DR: Insider sales are disclosed but totals are small relative to outstanding shares, suggesting limited immediate market impact.

The filing documents a planned sale of 10,000 shares and three prior monthly sales of 10,000 shares each by the named insider. Combined, the reported transactions total 40,000 shares sold or intended to be sold. Compared with the stated 1,240,806,916 shares outstanding, these disposals represent a de minimis percentage of the float. The shares were acquired as restricted stock on 03/01/2022, indicating these are not open-market purchases but distributions of previously restricted awards. From a market-impact perspective, the absolute dollar amounts (~$1.1m per 10,000-share tranche) are modest for a large-cap issuer.

Corporate Governance Expert

TL;DR: Repeated scheduled sales suggest personal liquidity actions rather than a governance red flag given disclosure and use of a broker.

The filer used a broker (Morgan Stanley Smith Barney LLC Executive Financial Services) and executed multiple monthly sales, with a further planned sale noted. The filing states the securities were restricted stock originally acquired from the issuer, and the notice includes the required representation about lack of undisclosed material information. There is no indication in the filing of unreported related-party transfers, gifts, or deviations from Rule 144 disclosure requirements. Governance implications appear routine based on the disclosed facts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	1136300.00	1240806916	08/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2022	Restricted Stock	ISSUER			10000	03/01/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	07/28/2025	10000	1139369.00
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	06/30/2025	10000	1104483.00
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	05/30/2025	10000	1104192.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider sales does the GILD Form 144 report?

The filing reports three recent sales of 10,000 shares each on 05/30/2025, 06/30/2025, and 07/28/2025, plus a proposed sale of 10,000 shares dated for 08/28/2025.

Who is the seller named in the GILD Form 144?

The seller named is Daniel O'Day, with an address listed as 333 Lakeside Drive Foster City CA 94404.

How many shares outstanding does the filing list for Gilead?

The filing lists 1,240,806,916 shares outstanding.

What was the acquisition type and date for the shares to be sold?

The 10,000 shares to be sold were acquired as restricted stock on 03/01/2022 from the issuer.

Through which broker will the planned sale be executed?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.